A drug with the SMILES C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCC[NH+]=C(N)N)nn3)CC2)nc(N2CCN(C(=O)[C@H]([C@@H](C)O)n3cc(CCCC[NH3+])nn3)CC2)n1.[Cl-] has a hERG inhibition at a concentration of 1uM of 3.479\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCC[NH+]=C(N)N)nn3)CC2)nc(N2CCN(C(=O)[C@H]([C@@H](C)O)n3cc(CCCC[NH3+])nn3)CC2)n1.[Cl-]
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCC[NH+]=C(N)N)nn3)CC2)nc(N2CCN(C(=O)[C@H]([C@@H](C)O)n3cc(CCCC[NH3+])nn3)CC2)n1.[Cl-]
3-[1-[2-[4-[4-[4-[(2S,3R)-2-[4-(4-azaniumylbutyl)triazol-1-yl]-3-hydroxybutanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-2-oxoethyl]triazol-4-yl]propyl-(diaminomethylidene)azanium;chloride